CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,012 enrolled
Drug / intervention
insulin degludec/liraglutide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02501161
NCT02501161Phase 3Completed
CompareCT.gov

A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S·interventional·Posted Jul 17, 2015·Updated Nov 27, 2019

In Brief

A Phase 3 clinical trial evaluating insulin degludec/liraglutide and insulin glargine for Diabetes and Diabetes Mellitus, Type 2. Completed, enrolled 1,012 participants across 143 sites in 16 countries.

Detailed Summary

This trial is conducted in Africa, Asia, Europe, North America and South America. The purpose is to compare long-term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) in insulin naïve subjects with type 2 diabetes mellitus inadequately controlled with oral anti diabetics.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Diabetes Mellitus, Type 2
CountriesArgentina, Brazil, Czechia, Hungary, India, Israel, Italy, Mexico, Norway, Poland, Russia, Slovakia, South Africa, Turkey (Türkiye), United Kingdom, United States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 17, 2015
Enrollment StartJan 31, 2016
Primary CompletionOct 3, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 11.0 years ago

Interventions

insulin degludec/liraglutidedrug

Injected subcutaneously (under the skin) once daily for 104 weeks. Dose individually adjusted.

insulin glarginedrug

Injected subcutaneously (under the skin) once daily for 104 weeks. Dose individually adjusted.